Lazard Capital Starts Nektar Therapeutics (NKTR) at Buy
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Price: $73.64 --0%
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Join SI Premium – FREE
Lazard Capital initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy. PT $15.00.
For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $8.74 yesterday.
For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $8.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Starts Aktis Oncology (AKTS) at Outperform
- Jefferies Starts Hesai (2525:HK) (HSAI) at Buy
- BMO Capital Starts Ionis Pharmaceuticals (IONS) at Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
